Better Pain Management Through Better Data Act of 2018

United States115th CongressHR-5473House of Representatives
Updated: Jun 13, 2018

Summary

Better Pain Management Through Better Data Act of 2018 This bill directs the Food and Drug Administration (FDA) to update or issue guidance for drug sponsors on data collection related to the use of other pain medication to reduce the need for opioids. The guidance must address alternative methods for data collection, product labeling, and investigations other than clinical trials.

Bill texts

Available versions
View official text

3 versions available

All available records shown.

Timeline

  1. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5031-5032)

    House of Representatives

  2. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5031-5032)

  3. Motion to reconsider laid on the table Agreed to without objection.

    House of Representatives

  4. Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate